Ireland· IE-PA-PA1113/012/002
Sanomigran 1.5mg Tablets
A pizotifen product containing pizotifen, registered in Ireland by Phoenix Labs. The same ATC class is registered in 7 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Pizotifen is registered in 7 of 19 countries.
Countries holding a registration under ATC N02CX01 (pizotifen), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 3 of them publish a price we can compare per daily dose
Pizotifen · ATC N02CX01
7 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- United Kingdom
The record
At a glance
HPRA (Ireland)- Active substance
- Pizotifen
- Manufacturer
- Phoenix Labs
- Country
- Ireland (IE)
- ATC code
- N02CX01
- ATC class
- Pizotifen
- Defined daily dose
- 1.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1113/012/002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Pizotifen in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomPizotifen 1.5mg tabletsA A H Pharmaceuticals Ltd
- CanadaSANDOMIGRAN DSENDO OPERATIONS LTD.
- SpainMOSEGOR 0,5 mg/10 ml SOLUCION ORALEthyx Pharmaceuticals
- FranceSANMIGRAN 0,50 mg, comprimé enrobéPHOENIX LABS (IRLANDE)
- NetherlandsSandomigran 0,5 mg, omhulde tabletten 0,5 mgPhoenix Labs
- BelgiumSandomigran 0,5 mgNovartis Pharma
- NorwaySandomigrinEthyx Pharmaceuticals SAS
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Cyprus · Pizogran
- Spain · Mosegor
- United Kingdom (Northern Ireland) · Pizotifen Tillomed Laboratories
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c25b07ef-0fbd-4060-9667-de9e859261c3 GET /v1/drugs/c25b07ef-0fbd-4060-9667-de9e859261c3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"N02CX",
"N02CX01"
],
"strength": null,
"pa_number": "PA1113/012/002",
"substances": [
"Pizotifen"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "07/09/1994",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about pizotifen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.